Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B Cell Depleting Therapy with COVID-19: A Target Trial Emulation Study.

Yiying Fan

doi:10.1093/cid/ciaf521

Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B Cell Depleting Therapy with COVID-19: A Target Trial Emulation Study.

Yiying Fan

Mathematics and Statistics

Research output: Contribution to journal › Article

Original language	English
Journal	Clinical Infectious Diseases
Volume	81
DOIs	https://doi.org/10.1093/cid/ciaf521
State	Published - 2025

Access to Document

10.1093/cid/ciaf521

Cite this

@article{0ad64602a72042f1b70d38e190636b12,

title = "Effectiveness of Nirmatrelvir/Ritonavir or Molnupiravir Use in Immunocompromised Patients on B Cell Depleting Therapy with COVID-19: A Target Trial Emulation Study.",

author = "Yiying Fan",

year = "2025",

doi = "10.1093/cid/ciaf521",

language = "English",

volume = "81",

journal = "Clinical Infectious Diseases",

}